<DOC>
	<DOCNO>NCT02633462</DOCNO>
	<brief_summary>The Purpose study ass correlation inflammatory periodontal status medical treatment status Polycystic Ovary Syndrome ( PCOS ) woman systemic inflammation evaluate effect non-surgical periodontal therapy form scale root plan along medical treatment level serological marker inflammation ( High sensitivity-C Reactive Protein ) insulin resistance PCOS woman chronic periodontitis .</brief_summary>
	<brief_title>Non-surgical Periodontal Therapy Myo-inositol Polycystic Ovary Syndrome Women Having Chronic Periodontitis</brief_title>
	<detailed_description>Polycystic Ovary Syndrome ( PCOS ) genetically complex endocrine disorder uncertain etiology common cause hyperandrogenism , anovulatory infertility , menstrual dysfunction , hirsutism , alopecia acne . It first report Stein Leventhal 1935 . It affect 6-8 % woman reproductive age . Accordingly PCOS might view gender specific form metabolic syndrome . According Androgen Excess Society ( AES ) /2006 criterion PCOS define presence hyperandrogenism ( clinical and/or biochemical ) , Oligo anovulation , Polycystic ovarian morphology ( PCOM ) - least one ovary 1 ) 12 follicle ( 2-9 mm diameter ) 2 ) Ovarian volume &gt; 10 ml . Patients PCOS high risk develop cardiovascular risk factor diabetes , insulin resistance , visceral obesity state low grade inflammation.Therefore , PCOS may represent model study complex interaction among Cardiovascular risk factor , especially chronic inflammation insulin resistance . Visceral obesity , insulin resistance hyperinsulinemia prevalent co-morbidities PCOS promote androgen excess.Insulin resistance PCOS due post-receptor defect insulin receptor mediate cell lead induce decrease glucose transporter . Therefore , reduction insulin secretion and/or improvement action target tissue offer possibility improve effect androgen excess correction reproductive dysfunction prevent metabolic derangement become entrench . For purpose many insulin-sensitizing agent like metformin try treatment modality metabolic well reproductive dysfunction PCOS.Myo-inositol ( MI ) naturally occur substance produce human body belong vitamin B complex group.PCOS link deficiency myo-inositol . MI synthesize body food , investigator already deficient , lack MI impact ability body sensitive insulin . MI play important role structural basis number secondary messenger include synthesis phosphatidylinositol 3-kinase ( PI 3-kinase ) , key messenger improve insulin sensitivity thereby reduce insulin resistance Supplying extra MI appear temporarily correct impaired insulin pathway reduce sign symptom insulin resistance . Periodontal disease , include gingivitis common chronic infectious disease characterize gingival inflammatory response predominantly pathogenic microorganism colonize subgingival area cause local systemic elevation proinflammatory cytokine , tumor necrosis factor-a interleukin-6 result loss connective tissue attachment , alveolar bone resorption result tooth loss . It well establish patient suffer periodontitis present low grade systemic inflammatory state compare healthy subjects.Increased concentration inflammatory biomarkers gingival tissue serum C-reactive protein interleukin report . Periodontal disease implicate risk factor onset development various cardiovascular disease like diabetes mellitus cerebrovascular coronary artery diseases.9,10,13 Chronic stimulation secretion proinflammatory cytokine associate periodontal infection contribute insulin resistance patient . Insulin resistance syndrome type 2 diabetes mellitus PCOS link slightly elevate serum C-reactive protein . As already discuss , Periodontitis also link elevated CRP level , therefore postulate CRP might possible mediator association periodontitis systemic diseases1 Because fact periodontal disease metabolic syndrome associate systemic inflammation insulin resistance , two disorder may link common pathophysiologic pathway . Earlier many cross-sectional study describe possible relationship PCOS periodontitis impact PCOS gingival inflammation However , take account medical treatment status , duration type treatment modality employ medical treatment syndrome . They also evaluate effect periodontal therapy periodontium , systemic inflammation insulin resistance PCOS woman suffer inflammatory periodontal disease . Therefore study , investigator aim assess correlation inflammatory periodontal status medical treatment status PCOS patient systemic inflammation evaluate effect non surgical periodontal therapy along medical treatment level serological marker inflammation ( High sensitivity-CRP ) insulin resistance . MATERIALS AND METHOD : This study conduct department Periodontics Oral Implantology , Post Graduate Institute Dental Sciences ( PGIDS ) , Rohtak collaboration department Obstetrics Gynaecology , Post Graduate Institute Medical Sciences ( PGIMS ) , Rohtak STUDY POPULATION AND DESIGN : The study conduct follow : Patients ( n=25 per group ) interventional study recruit regular OPD ( Out Patient Department ) Dept . Periodontology , Dept . Obstetrics Gynaecology dept . Oral Medicine . GROUP A : Systemically periodontally healthy female ( Age BMI match ) also recruit department oral medicine . INTERVENTIONAL STUDY An Randomized clinical trial do evaluate effect Non-surgical periodontal therapy along myoinositol systemic inflammatory marker , insulin resistance , anthropometric periodontal parameter newly diagnose patient PCOS periodontal disease . They divide follow group : Women Polycystic ovarian syndrome ( PCOS ) chronic periodontitis randomly divide two group : Test Group : Polycystic ovarian syndrome ( PCOS ) woman periodontitis treated scaling root plan along Myo-inositol supplementation ( 1 gm twice day ) Control Group : Polycystic ovarian syndrome ( PCOS ) woman periodontitis treat Myo-inositol ( 1 gm twice day ) along oral hygiene instruction INCLUSION CRITERIA : - Females reproductive age group ( 15-35 yr ) - Subjects diagnose PCOS accord Androgen Excess Society ( AES ) /2006 criterion : - Presence hyperandrogenism ( clinical and/or biochemical ) - Oligo anovulation - PCOM ( Polycystic ovarian morphology ) - least one ovary 1 ) 12 follicle ( 2-9 mm diameter ) 2 ) Ovarian volume &gt; 10 ml - Presence ≥20 natural teeth - Patients Chronic Periodontitis define accord division Oral Health Centers Disease Control Prevention ( CDC ) collaboration American Academy Periodontology ( AAP ) Moderate periodontitis : ≥ 2 interproximal site AL , ≥4 mm ( tooth ) , ≥2 interproximal site PD ≥5 mm ( tooth ) ( Page Eke 2007 ) EXCLUSION CRITERIA - Any history thyroid dysfunction , hyperprolactinemia , androgen -secreting tumour , nephrotic syndrome , chronic renal failure . - Significant cardiovascular disease . - Established type 1 type 2 diabetes mellitus . - Active cancer within last past 5 yr . - Smokers alcoholic subject . - History systemic antibiotic oral contraceptive usage within last 3 month . - Periodontal treatment within 6 month prior study Prior inform consent take patient explain procedure along risk benefit language . All subject study undergo examination various anthropometric , metabolic periodontal parameter ultrasonography . Anthropometric Metabolic parameters re-evaluated recall period 6 month . ANTHROPOMETRIC PARAMETERS - Waist circumference - Waist hip ratio - Body mass index METABOLIC PARAMETERS - Serum ( Follicle Stimulating Harmone ) FSH/ ( Leutinising Harmone ) LH - Fasting Blood sugar - Serum testosterone - Serum Prolactin - Lipid profile - Serum hsCRP - Fasting Insulin Parameter insulin resistance - Homeostatic Model Assessment ( HOMA ) insulin resistance ( IR ) It product fast value glucose ( express mg/dl ) insulin express µU/ml ( micron unit/millilitre ) divide constant : Insulin×Glucose/405 The constant 405 replace 22.5 glucose express Standard International ( SI ) unit ( mmol/l ) Sample metabolic parameter collect second third day menstrual cycle . PERIODONTAL PARAMETERS - Plaque index ( PI ) ( Silness &amp; Loe ) - Gingival index ( GI ) ( Loe &amp; Silness ) - Bleeding probing ( BOP ) - Pocket depth ( PD ) - Clinical attachment level ( CAL ) Each tooth assess six site ( mesio-buccal , mid-buccal , disto-buccal , mesio-lingual/palatal , mid-lingual/palatal disto-lingual/palatal ) Bleeding probing , Pocket depth Clinical attachment level four site ( mesio-buccal , mid-buccal , disto-buccal mid-lingual/palatal ) plaque index gingival index full mouth complete periodontal examination.Periodontal parameter evaluate 3 6 month . Processing Of Data : Data record processed standard statistical analysis .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>Females reproductive age group ( 1535 yr ) Subjects diagnosed PCOS accord AES ( Androgen Excess Society ) /2006 criterion : Presence hyperandrogenism ( clinical and/or biochemical ) Oligo anovulation PCOM ( Polycystic ovarian morphology ) least one ovary 1 ) 12 follicle ( 29 mm diameter ) 2 ) Ovarian volume &gt; 10 ml Presence ≥20 natural teeth Patients Chronic Periodontitis define accord division Oral Health Centers Disease Control Prevention ( CDC ) collaboration American Academy Periodontology ( AAP ) Moderate periodontitis : ≥ 2 interproximal site AL , ≥4 mm ( tooth ) , ≥2 interproximal site PD ≥5 mm ( tooth ) ( Page Eke 2007 ) Any history thyroid dysfunction , hyperprolactinemia , androgen secrete tumour , nephrotic syndrome , chronic renal failure . Significant cardiovascular disease . Established type 1 type 2 diabetes mellitus . Active cancer within last past 5 yr . Smokers alcoholic subject . History systemic antibiotic oral contraceptive usage within last 3 month . Periodontal treatment within 6 month prior study</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>